Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 4 | 10 | | 10 |
% Growth | NA | NA | 109.1% | 3314.3% | 440.8% | -34.8% | -24.9% | 286.7% | 65.6% | 146.1% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | (0) | (0) | (0) | (0) | (0) | (0) | (1) | (2) | (6) | | (6) |
Gross Profit | 0 | 0 | (0) | 0 | 1 | 1 | 0 | 1 | 2 | 4 | | 4 |
% Revenue | NA | 21.7% | -12.3% | 33.5% | 73.6% | 72.7% | 69.9% | 54.3% | 59.2% | 37.3% | | 41.5% |
| | | | | | | | | | | | |
Research and Development | 0 | (0) | (0) | (1) | (1) | (1) | (0) | (2) | (4) | (6) | | (4) |
Selling and Marketing | 0 | 0 | 0 | (0) | (0) | (0) | (0) | (0) | (1) | (2) | | (2) |
General and Admin | 0 | (0) | (0) | (2) | (2) | (2) | (2) | (11) | (16) | (18) | | (15) |
Other Inc / (Exp) | 0 | 0 | (0) | (0) | 0 | 0 | (0) | (0) | 0 | 0 | | (0) |
Total Operating Exp | 0 | (1) | (1) | (2) | (3) | (3) | (3) | (13) | (20) | (26) | | (21) |
| | | | | | | | | | | | |
Operating Income | 0 | (1) | (1) | (2) | (2) | (2) | (2) | (12) | (18) | (22) | | (17) |
% Revenue | NA | -20420.5% | -11937.8% | -1024.5% | -161.5% | -238.2% | -375.5% | -488.2% | -450.3% | -226.3% | | -172.3% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | (0) | (0) | (0) | (1) | (0) | (1) | (1) | | (1) |
Pre-tax Income | 0 | (1) | (1) | (2) | (2) | (2) | (3) | (12) | (19) | (24) | | (18) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | (0) | (0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Company | 0 | (1) | (1) | (2) | (2) | (2) | (3) | (12) | (19) | (24) | | (18) |
% Margin | NA | -20441.3% | -11917.8% | -1029.1% | -161.6% | -238.4% | -456.8% | -493.7% | -486.6% | -241.0% | | -186.5% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 0 | (1) | (1) | (2) | (2) | (2) | (3) | (12) | (19) | (24) | | (18) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | (0) | (3) | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 0 | (1) | (1) | (2) | (2) | (2) | (3) | (15) | (19) | (24) | | (18) |
% Margin | NA | -20441.3% | -11917.8% | -1029.1% | -161.6% | -238.4% | -457.0% | -602.4% | -486.6% | -241.0% | | -186.5% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | (0.05) | (0.02) | (0.04) | (0.03) | (0.02) | (0.03) | (0.15) | (0.18) | (0.20) | | (0.11) |
Diluted EPS (Continuing Ops) | 0.00 | (0.05) | (0.02) | (0.04) | (0.03) | (0.02) | (0.03) | (0.15) | (0.18) | (0.20) | | (0.11) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.00 | 12.81 | 42.99 | 63.98 | 77.64 | 80.12 | 82.03 | 95.75 | 105.66 | 117.82 | | 176.02 |
WA Diluted Shares Out. | 0.00 | 12.81 | 42.99 | 63.98 | 77.64 | 80.12 | 82.03 | 95.75 | 105.66 | 117.82 | | 176.02 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 0 | (1) | (1) | (2) | (2) | (2) | (3) | (12) | (19) | (24) | | (18) |
Addback: Net Interest Expense | 0 | (0) | (0) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | | 1 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | (0) | (0) | 0 | 0 | (0) | (0) | | 0 |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | | 2 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | | 0 |
Adjusted EBITDA | 0 | (1) | (1) | (2) | (2) | (2) | (2) | (11) | (18) | (20) | | (14) |
% Margin | NA | -20402.0% | -11928.2% | -1020.8% | -162.2% | -236.3% | -372.6% | -474.4% | -451.3% | -205.5% | | -148.9% |
| | | | | | | | | | | | |
Adjusted EBIT | 0 | (1) | (1) | (2) | (2) | (2) | (2) | (12) | (18) | (22) | | (17) |
% Margin | NA | -20420.5% | -11937.8% | -1024.5% | -163.4% | -238.4% | -375.1% | -477.2% | -457.8% | -228.0% | | -171.8% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 0 | (1) | (1) | (2) | (2) | (2) | (3) | (12) | (19) | (24) | | (18) |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | 0 | | (0) |
Adjusted Net Income | 0 | (1) | (1) | (2) | (2) | (2) | (3) | (12) | (20) | (24) | | (18) |
% Margin | NA | -20441.3% | -11917.8% | -1029.1% | -161.6% | -238.4% | -456.8% | -489.4% | -489.3% | -241.0% | | -186.3% |